The dexlansoprazole market is driven by its use as a proton pump inhibitor (PPI) for treating gastroesophageal reflux disease (GERD) and related conditions [1]. This drug is available in various formulations, including extended-release capsules [1].
When might generic dexlansoprazole become available?
The patent landscape for dexlansoprazole influences when generic versions can enter the market. Drug patent expiry dates are crucial for anticipating generic competition. Information on dexlansoprazole's patent status can be found through resources like DrugPatentWatch.com [2].
What conditions does dexlansoprazole treat?
Dexlansoprazole is prescribed for healing erosive esophagitis, maintaining that healing, and managing heartburn associated with GERD [1].
How does dexlansoprazole work?
As a proton pump inhibitor, dexlansoprazole works by decreasing the amount of acid produced by the stomach. It achieves this by irreversibly blocking the H+/K+-ATPase enzyme system in gastric parietal cells, which is the final step in gastric acid production [1].
What are the side effects of dexlansoprazole?
Common side effects reported with dexlansoprazole include diarrhea, nausea, headache, and abdominal pain [1].
What other drugs are in the same class as dexlansoprazole?
Dexlansoprazole belongs to the proton pump inhibitor (PPI) class, which also includes drugs like omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole [1]. These medications share a similar mechanism of action in reducing stomach acid.
What is the pricing of dexlansoprazole?
The price of dexlansoprazole can vary based on factors such as dosage, quantity, insurance coverage, and the pharmacy chosen [3]. Generic options, when available, typically offer a lower price point compared to brand-name versions.
Who manufactures dexlansoprazole?
Takeda Pharmaceuticals is the original manufacturer of dexlansoprazole, marketed under the brand name Dexilant [1]. Following patent expirations, other pharmaceutical companies may produce and market generic versions.
What is the difference between dexlansoprazole and lansoprazole?
Dexlansoprazole is an enantiomer of lansoprazole, meaning it is a specific stereoisomer of the drug. It is formulated with dual delayed-release technology, which allows for two distinct pH-dependent releases of dexlansoprazole in the gastrointestinal tract. This formulation is designed to provide prolonged acid suppression compared to some other PPIs [1].
What is the market size for GERD treatments?
The market for GERD treatments is substantial, driven by the high prevalence of the condition worldwide. This market includes various drug classes, such as PPIs, H2 blockers, and antacids, as well as surgical and lifestyle interventions [4].
Are there alternatives to dexlansoprazole?
Beyond other PPIs, alternative treatments for GERD include H2 receptor antagonists, antacids, lifestyle modifications (such as dietary changes and weight management), and in some cases, surgery [4].
Sources:
[1] https://www.drugguide.com/ddtranslate/drug-monograph/dexlansoprazole-oral
[2] https://www.drugpatentwatch.com/
[3] https://www.goodrx.com/dexlansoprazole
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158159/